MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

CEO

ISIN

BE0974461940

WKN

000A3E19Y

Listings

0 Comments

Share your thoughts

FAQ

What is MDxHealth SA stock price today?▼

The current price of O6C1.F is €1.53 EUR — it has increased by +7.75% in the past 24 hours. Watch MDxHealth SA stock price performance more closely on the chart.

What is MDxHealth SA stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange MDxHealth SA stocks are traded under the ticker O6C1.F.

When is the next MDxHealth SA earnings date?▼

MDxHealth SA is going to release the next earnings report on May 14, 2026.

What were MDxHealth SA earnings last quarter?▼

O6C1.F earnings for the last quarter are -0.14 EUR per share, whereas the estimation was -0.11 EUR resulting in a -35.48% surprise. The estimated earnings for the next quarter are N/A EUR per share.

In which sector is MDxHealth SA located?▼

MDxHealth SA operates in the Other sector.

When did MDxHealth SA complete a stock split?▼

The last stock split for MDxHealth SA was on November 14, 2023 with a ratio of 1:10.